KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Non-Current Deferred Tax Liability (2016 - 2018)

Vertex Pharmaceuticals has reported Non-Current Deferred Tax Liability over the past 10 years, most recently at $9.4 million for Q3 2018.

  • Quarterly results put Non-Current Deferred Tax Liability at $9.4 million for Q3 2018, down 11.87% from a year ago — trailing twelve months through Sep 2018 was $9.4 million (down 11.87% YoY), and the annual figure for FY2017 was $6.3 million, down 95.27%.
  • Non-Current Deferred Tax Liability for Q3 2018 was $9.4 million at Vertex Pharmaceuticals, up from $9.3 million in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for VRTX hit a ceiling of $136.6 million in Q2 2017 and a floor of $6.3 million in Q4 2017.
  • Median Non-Current Deferred Tax Liability over the past 5 years was $111.2 million (2015), compared with a mean of $74.6 million.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: soared 853.6% in 2015 and later plummeted 95.27% in 2017.
  • Vertex Pharmaceuticals' Non-Current Deferred Tax Liability stood at $11.5 million in 2014, then soared by 853.6% to $110.1 million in 2015, then grew by 21.78% to $134.1 million in 2016, then tumbled by 95.27% to $6.3 million in 2017, then surged by 48.46% to $9.4 million in 2018.
  • The last three reported values for Non-Current Deferred Tax Liability were $9.4 million (Q3 2018), $9.3 million (Q2 2018), and $9.6 million (Q1 2018) per Business Quant data.